The revenue in May for Zinzino‘s sales markets increased by 58 % and amounted to SEK 277.6 (175.5) million.
Faun Pharma’s external sales decreased and amounted to SEK 7.6 (9.5) million. Overall, the Group increased revenues by 54 % to SEK 285.2 (185.0) million compared with the previous year.
Accumulated revenue for January – May 2025 increased by 57 % to SEK 1,261.7 (805.6) million.
Revenues were distributed as follows:
Regions,MSEK
25-May
24-May
Change
YTD 2025
YTD 2024
Change
The Nordics
29.3
25.7
14%
129.8
118.8
9%
Central Europe
74.0
49.5
49%
335.1
214.5
56%
East Europe
36.7
34.8
5%
161.1
159.6
1%
South & West Europe
49.3
34.2
44%
218.1
131.2
66%
The Baltics
11.5
8.8
31%
48.8
40.8
20%
North America
47.3
16.4
188%
212.1
67.1
216%
Asia-Pacific
27.5
4.8
473%
118.5
22.6
424%
Africa
2.0
1.3
54%
8.5
5.7
49%
Zinzino
277.6
175.5
58%
1,232.0
760.3
62%
Faun Pharma
7.6
9.5
-20%
29.7
45.3
-34%
Zinzino Group
285.2
185.0
54%
1,261.7
805.6
57%
Countries in regions:
-The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
-Central Europe: Austria, Germany, Switzerland
-East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
-South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
-The Baltics: Estonia, Latvia, Lithuania
-North America: Canada, USA, Mexico
-Asia-Pacific: Australia, New Zealand, Hong Kong, India, Malaysia, Singapore, Taiwan, Thailand, China
-Africa: South Africa
About Zinzino
Zinzino is a global direct sales company from Scandinavia specializing in test-based, personalized nutrition and scientific skincare. It is a public limited company with its shares listed on Nasdaq First North Premier Growth Market. Their scientifically proven nutritional supplements are available in more than 100 markets across the world.
Zinzino has acquired all assets in the health and wellness companies Zurvita and Xelliss. The company co-owns the Cypriot olive oil